Concentrations of thioredoxin, a redox-regulating protein, in umbilical cord blood and breast milk

References

• Saugstad OD. Update on oxygen radical disease in neonato-logy. Curr Opin Obstet Gynecol 2001;13:147–153.
   PubMed Web of Science ®Google Scholar
• Dennery PA. Role of redox in fetal development and neonatal diseases. Antioxid Redox Signal 2004;6:147–153.
   PubMed Web of Science ®Google Scholar
• Das KC. Thioredoxin system in premature and newborn biology. Antioxid Redox Signal 2004;6:177–184.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 1997;15:351–369.
   PubMed Web of Science ®Google Scholar
• Nordberg J, Amer ESJ. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001;31:1287–1312.
   PubMed Web of Science ®Google Scholar
• Okubo K, Kosaka S, Isowa N, Hirata T, Hitomi S, Yodoi J, Nakano M, Wada H. Amelioration of ischemia-reperfusion injury by human thioredoxin in rabbit lung. J Thorac Cardiovasc Surg 1997;113:1–9.
   PubMed Web of Science ®Google Scholar
• Hattori I, Takagi Y, Nakamura H, Nozaki K, Bai J, Kondo N, Sugino T, Nishimura M, Hashimoto N, Yodoi J. Intravenous administration of thioredoxin decreases brain damage follow-ing transient focal cerebral ischemia in mice. Antioxid Redox Signal 2004;6:81–87.
   PubMed Web of Science ®Google Scholar
• Takagi Y, Mitsui A, Nishiyama A, Nozaki K, Sono H, Gon Y, Hashimoto N, Yodoi J. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci USA 1999;96:4131–4136.
   PubMed Web of Science ®Google Scholar
• Shioji K, Kishimoto C, Nakamura H, Masutani H, Yuan Z, Oka S, Yodoi J. Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circula-tion 2002;106: 1403–1409.
   Google Scholar
• Mitsui A, Hamuro J, Nakamura H, Kondo N, Hirabayashi Y, Ishizaki-Koizumi S, Hirakawa T, Inoue T, Yodoi J. Over-expression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid Redox Signal 2002;4:693–696.
   Google Scholar
• Kobayashi-Miura M, Nakamura H, Yodoi J, Shiota K. Thioredoxin, an anti-oxidant protein, protects mouse embryos from oxidative stress-induced developmental anomalies. Free Radic Res 2002;36:949–956.
   Google Scholar
• Nakamura H, De Rosa S, Roederer M, Anderson MT, Dubs JG, Yodoi J, Holmgren A, Herzenberg LA, Herzenberg LA. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 1996;8:603–611.
   PubMed Web of Science ®Google Scholar
• Abdiu A, Nakamura H, Sahaf B, Yodoi J, Holmgren A, Rosen A. Thioredoxin blood levels increases after severe burn injury. Antiox Redox Signal 2000;2:707–716.
   PubMed Web of Science ®Google Scholar
• Sumida Y, Nakashima T, Yoh T, Nakajima Y, Ishikawa H, Mitsuyoshi H, Sakamoto Y, Okanoue T, Kashima K, Nakamura H, Yodoi J. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J Hepatol 2000;33:616–622.
   Google Scholar
• Jikimoto T, Nishikubo Y, Koshiba M, Kanagawa S, Morinobu S, Morinobu A, Saura R, Mizuno K, Kondo S, Toyokuni S, Nakamura H, Yodoi J, Kumagai S. Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol Immunol 2001;38:765–772.
   Google Scholar
• Kakisaka Y, Nakashima T, Sumida Y, Yoh T, Nakamura H, Yodoi J, Senmaru H. Elevation of serum thioredoxin levels in patients with type 2 diabetes. Horm Metab Res 2002;34: 160–164.
   Google Scholar
• Hirai N, Kawano H, Yasue H, Shimomura H, Miyamoto S, Soejima H, Kajiwara I, Sakamoto T, Yoshimura M, Nakamura H, Yodoi J, Ogawa H. Attenuation of nitrate tolerance and oxidative stress by an angiotensin II receptor blocker in patients with coronary spastic angina. Circulation 2003;108:1446–1450.
   PubMed Web of Science ®Google Scholar
• Miwa K, Kishimoto C, Nakamura H, Makita T, Ishii K, Okuda N, Taniguchi A, Shioji K, Yodoi J, Sasayama S. Increased oxidative stress with elevated serum thioredoxin level in patients with coronary spastic angina. Clin Cardiol 2003;26:177–181.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Nakamura H, Adachi T, Sannohe S, Oyamada H, Kayaba H, Yodoi J, Chihara J. Elevated serum levels of thioredoxin in patients with acute exacerbation of asthma. Immunol Lett 2003;86:199–205.
   PubMed Web of Science ®Google Scholar
• Shibata E, Ejima K, Nanri H, Toki N, Koyama C, Ikeda M, Kashimura M. Enhanced protein levels of protein thiol/di-sulphide oxidoreductases in placentae from pre-eclamptic subjects. Placenta 2001;22:566–572.
   Google Scholar
• Yamashita S, Yamamoto Y. Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Anal Biochem 1997;250:66–73.
   PubMed Web of Science ®Google Scholar
• Hara K, Yamashita S, Fujisawa A, Ishiwa S, Ogawa T, Yamamoto Y. Oxidative stress in newborn infants with and without asphyxia as measured by plasma antioxidants and free fatty acids. Biochem Biophys Res Commun 1999;257:244–248.
   PubMed Web of Science ®Google Scholar
• Fujii S, Nanbu Y, Konishi I, Mori T, Masutani H, Yodoi J. Immunohistochemical localization of adult T-cell leukaemia-derived factor, a human thioredoxin homologue, in human fetal tissues. Virchows Archiv A Pathol Anat 1991; 419:317–326.
   Google Scholar
• Kobayashi F, Sagawa N, Nanbu Y, Kitaoka Y, Mori T, Fujii S, Nakamura H, Masutani H, Yodoi J. Biochemical and topological analysis of adult T-cell leukaemia-derived factor, homologous to thioredoxin, in the pregnant human uterus. Hum Reprod 1995;10:1603–1608.
   Google Scholar
• Ejima K, Nanri H, Toki N, Kashimura M, Ikeda M. Localization of thioredoxin reductase and thioredoxin in normal human placenta and their protective effect against oxidative stress. Placenta 1999;20:95–101.
   Google Scholar
• Matsui M, Oshima M, Oshima H, Takak-u K, Maruyama T, Yodoi J, Taketo MM. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev Biol 1996;178:179–185.
   Google Scholar
• Madazli R, Benian A, Aydin S, Uzun H, Tolun N. The plasma and placental levels of malondialdehyde, glutathione and superoxide dismutase in pre-eclampsia. J Obstet Gynaecol 2002;22:477–480.
   Google Scholar
• Roberts JM, Lain KY. Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002;23:359–372.
   PubMed Web of Science ®Google Scholar
• Wijnberger LDE, Krediet TG, Visser GHA, van Bel F, Egberts J. Early neonatal antioxidant capacity after preexisting impaired placental function. Early Hum Dev 2003;71:111–116.
   Google Scholar
• Tsukahara H, Ohta N, Sato S, Hiraoka M, Shukunami K, Uchiyama M, Kawakami H, Sekine K, Mayumi M. Concentrations of pentosidine, an advanced glycation end-product, in umbilical cord blood. Free Radic Res 2004;38:691–695.
   Google Scholar
• Watkins CJ, Leeder SR, Corkhill RT. The relationship between breast and bottle feeding and respiratory illness in the first year of life. J Epidemiol Community Health 1979;33:180–182.
   Google Scholar
• Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990;336:1519–1523.
   PubMed Web of Science ®Google Scholar
• Ashraf RN, Jalil F, Zaman S, Karlberg J, Khan SR, Lindblad BS, Hanson LA. Breast feeding and protection against neonatal sepsis in a high risk population. Arch Dis Child 1991;66:488–490.
   Google Scholar
• Lindmark-Mansson H, Akesson B. Antioxidative factors in milk. Br J Nutr 2000;84\(Suppl. 1):S103–S110.
   Google Scholar
• Shoji H, Oguchi S, Shimizu T, Yamashiro Y. Effect of human breast milk on urinary 8-hydroxy-2'-deoxyguanosine excretion in infants. Pediatr Res 2003;53:850–852.
   PubMed Web of Science ®Google Scholar
• Maruyama T, Sachi Y, Furuke K, Kitaoka Y, Kanzaki H, Yoshimura Y, Yodoi J. Induction of thioredoxin, a redox-active protein, by ovarian steroid hormones during growth and differentiation of endometrial stromal cells in vitro. Endocrino-logy 1999;140:365–372.
   Google Scholar
• Matsutani Y, Yamauchi A, Takahashi R, Ueno M, Yoshikawa K, Honda K, Nakamura H, Kato H, Kodama H, Inamoto T, Yodoi J, Yamaoka Y. Inverse correlation of thioredoxin expression with estrogen receptor- and p53-dependent tumor growth in breast cancer tissues. Clin Cancer Res 2001;7:3430–3436.
   PubMed Web of Science ®Google Scholar
• Varsila E, Pesonen E, Andersson S. Early protein oxidation in the neonatal lung is related to development of chronic lung disease. Acta Paediatr 1995;84:1296–1299.
   Google Scholar
• Ogihara T, Okamoto R, Kim HS, Nagai A, Morinobu T, Moji H, Kamegai H, Hirano K, Ogihara H, Tamai H, Mino M. New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease. Pediatr Res 1996;39:117–119.
   Google Scholar
• Lubec G, Widness JA, Hayde M, Menzel D, Pollak A. Hydroxyl radical generation in oxygen-treated infants. Pediatrics 1997;100:700–704.
   Google Scholar
• Ogihara T, Hirano K, Morinobu T, Kim HS, Hiroi M, Ogihara H, Tamai H. Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1999;80:F21–F25.
   Google Scholar
• Tsukahara H, Jiang MZ, Ohta N, Sato S, Tamura S, Hiraoka M, Maeda M, Mayumi M. Oxidative stress in neonates: Evaluation using specific biomarkers. Life Sci 2004;75:933–938.
   PubMed Web of Science ®Google Scholar
• Moison RMW, Haasnoot AA, van Zoeren-Grobben D, Berger HM. Red blood cell glutathione and plasma sulfhydryls in chronic lung disease of the newborn. Acta Paediatr 1997;86:1363–1369.
   Google Scholar
• Reise JA, Taylor GW, Fardy CH, Silverman M. Glutathione and neonatal lung disease. Clin Chim Acta 1997;265:113–119.
   PubMed Web of Science ®Google Scholar
• Das KC, Guo XL, White CW. Induction of thioredoxin and thioredoxin reductase gene expression in lungs of newborn primates by oxygen. Am J Physiol 1999;276(Lung Cell Mol Physiol 20):L530–L539.
   Google Scholar